Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Keratosis, Actinic 6Carcinoma, Basal Cell 4Uterine Cervical Dysplasia 3Squamous Intraepithelial Lesions 2HIV Infections 2Condylomata Acuminata 2Precancerous Conditions 1Patient Satisfaction 1Papillomavirus Infections 1Paget Disease, Extramammary 1Hutchinson's Melanotic Freckle 1Carcinoma, Squamous Cell 1Anus Neoplasms 1Acquired Immunodeficiency Syndrome 1

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 12Vaccines, Synthetic 9Vaccines 3Papillomavirus Vaccines 3Imiquimod 2Duration of Therapy 2human papillomavirus vaccine, L1 type 16, 18 1Viusid 1Vaccination 1Tuberculin 1Podophyllin 1PRA1 protein, Candida albicans 1Measles-Mumps-Rubella Vaccine 1Hepatitis B Vaccines 1Diathermy 1Cyclophosphamide 1Cryotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Condylomata Acuminata × Imiquimod × Clear all
NCT03289260 2020-09-23

AdAM

Medical University Innsbruck

Phase 3 Unknown
200 enrolled

Condylomata Acuminata

NCT00674739 2011-05-24

Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts

Graceway Pharmaceuticals, LLC

Phase 3 Completed
470 enrolled 11 charts

Condylomata Acuminata

Data powered by HemOnc (CC BY 4.0) Colophon âš¡